SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-004889
Filing Date
2019-02-27
Accepted
2019-02-27 16:05:33
Documents
5
Period of Report
2019-02-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20190227.htm 8-K 37667
2 EX-99.1 life-ex991_7.htm EX-99.1 21117
3 EX-99.2 life-ex992_6.htm EX-99.2 14115
4 GRAPHIC g1pehqht2mq4000001.jpg GRAPHIC 3121
5 GRAPHIC gsnh4gytq22c000001.jpg GRAPHIC 5618835
  Complete submission text file 0001564590-19-004889.txt   7815841
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 19637652
SIC: 2836 Biological Products, (No Diagnostic Substances)